Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

BRISTOL
FDA Approves Unknown Drug — BRISTOL

On April 17, 2025, Bristol received approval for a new drug application (NDA 220073), a development that is poised to reshape the competitive landscap...

CMG
FDA Approves Unknown Drug — CMG PHARM CO LTD

CMG PHARM CO LTD announced that its generic New Drug Application (NDA 211448) for [Insert Substance Name] was approved by the FDA on April 15, 2025, a...

Camber
FDA Approves IMATINIB MESYLATE — Camber Pharmaceuticals, Inc.

# FDA Approves Generic Imatinib Mesylate Camber Pharmaceuticals, Inc. has received FDA approval for its generic formulation of imatinib mesylate, an ...

Bionpharma
FDA Approves METFORMIN HYDROCHLORIDE ORAL SOLUTION — Bionpharma Inc.,

BIONPHARMA INC. announced the U.S. approval of generic metformin hydrochloride oral solution (ANDA 219151), a move that is expected to bolster supply ...

Fresenius
FDA Approves TYENNE — Fresenius Kabi USA, LLC

Fresenius Kabi USA announced on March 14, 2025, the FDA approval of its biosimilar TOCILIZUMAB (TYENNE), a fully human monoclonal antibody for injecti...

Scienture
FDA Approves ARBLI — Scienture LLC

# FDA Approves Scienture LLC's ARBLI (Losartan Potassium) for Oral Use The U.S. Food and Drug Administration has approved Scienture LLC's ARBLI (losa...

Camber
FDA Approves METFORMIN HYDROCHLORIDE — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals has received FDA approval for its generic Metformin HCl for oral administration, potentially generating additional revenue thro...

Encube
FDA Approves ESTRADIOL GEL — Encube Ethicals, Inc.

Encube Ethicals, Inc. announced on Tuesday, March 5th, that its generic estradiol topical gel has received FDA approval under application ANDA218507, ...

BIOCON
FDA Approves LENALIDOMIDE — BIOCON PHARMA INC.,

# FDA Approves BIOCON PHARMA's Generic Lenalidomide, Expanding Access to Key Multiple Myeloma Treatment BIOCON PHARMA INC. has received FDA approval ...

GENENTECH
FDA Approves Unknown Drug — GENENTECH INC

GENENTECH INC has received FDA approval for the drug indicated by NDA219285 on February 11, 2025, a decision that is expected to bolster the company's...

Slate
FDA Approves GADOTERIDOL — Slate Run Pharmaceuticals, LLC

Slate Run Pharmaceuticals has been granted FDA approval for its intravenous gadoteridol injection, granting the company access to the commercial marke...

Gland
FDA Approves EPINEPHRINE — Gland Pharma Limited

Gland Pharma Limited announced on Wednesday the FDA approval of its epinephrine injection for intramuscular use, API ANDA219239. This authorization ex...

Lupin
FDA Approves BOSENTAN — Lupin Pharmaceuticals, Inc.

# FDA Approves Generic Bosentan; Lupin Pharmaceuticals Enters Pulmonary Hypertension Market Lupin Pharmaceuticals, Inc. has received FDA approval for...

MDD
FDA Approves ONAPGO — MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc

Supernus Pharmaceuticals, Inc. announced the FDA approval of ONAPGO (apomorphine hydrochloride) for subcutaneous administration, a launch expected to ...

Macleods
FDA Approves TRAMADOL HYDROCHLORIDE — Macleods Pharmaceuticals Limited

Macleods Pharmaceuticals Limited obtained FDA approval for its generic Tramadol Hydrochloride oral tablets (ANDA209404), a milestone likely to drive r...

Granules
FDA Approves LISDEXAMFETAMINE DIMESYLATE — Granules Pharmaceuticals Inc.

Granules Pharmaceuticals Inc. received FDA approval on January 29 for its New Drug Application for lisdexexamfetamine dimethylate to market the generi...

CELLTRION
FDA Approves Unknown Drug — CELLTRION INC

On January 24, 2025, CELLTRION INC received FDA approval for the new product, a development that underscores the company's strong pipeline and is expe...

Rising
FDA Approves SPIRONOLACTONE — Rising Pharma Holdings, Inc.

Rising Pharma Holdings, Inc. received FDA approval Monday to market its generic version of the antihypertensive and diuretic Spirionolactone (ANDA2194...

Daiichi
FDA Approves DATROWAY — Daiichi Sankyo Inc.

# FDA Approves Daiichi Sankyo's DATROWAY (datopotamab deruxtecan) for Oncology Treatment Daiichi Sankyo Inc. received FDA approval for DATROWAY (dato...

YICHANG
FDA Approves Unknown Drug — YICHANG HUMANWELL

Yichang Humanwell announced the FDA’s approval of NDA ANDA219072 on January 16, setting the stage for a new market entrant and driving shareholder val...